Tested Applications
| Positive WB detected in | NIH/3T3 cells, rat brain tissue, HEK-293 cells |
| Positive IHC detected in | human skin cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | NIH/3T3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
22114-1-AP targets JUN in WB, IHC, IF/ICC, ChIP, ELISA applications and shows reactivity with human, mouse, rat, monkey samples.
| Tested Reactivity | human, mouse, rat, monkey |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag17419 Product name: Recombinant human AP1,JUN,P39 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-331 aa of BC002646 Sequence: MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDLLTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKNVTDEQEGFAEGFVRALAELHSQNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFSASLHSEPPVYANLSNFNPGALSSGGGAPSYGAAGLAFPAQPQQQQQPPHHLPQQMPVQHPRLQALKEEPQTVPEMPGETPPLSPIDMESQERIKAERKRMRNRIAASKCRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMNHVNSGCQLMLTQQLQTF Predict reactive species |
| Full Name | jun oncogene |
| Calculated Molecular Weight | 331 aa, 36 kDa |
| Observed Molecular Weight | 40-46 kDa |
| GenBank Accession Number | BC002646 |
| Gene Symbol | JUN |
| Gene ID (NCBI) | 3725 |
| RRID | AB_2750860 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P05412 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
啊⁎獩愠獬慮敭獡挠䨭湵愠摮†偁ⰱ戠汥湯獧琠桴婢偉映浡汩⁹湡畊畳晢浡汩䨠乕桴潭瑳攠瑸湥楳敶祬猠畴楤摥瀠潲整湩漠桴捡楴慶潴牰瑯楥‱䄨ⵐ⤱挠浯汰硥獩椠癮汯敶湩渠浵牥畯散汬愠瑣癩瑩敩ⱳ猠捵獡瀠潲楬敦慲楴湯灡灯潴楳ⱳ猠牵楶慶ⱬ琠浵牯杩湥獥獩愠摮琠獩畳潭灲潨敧敮楳倨䥍㩄㈠ㄲ〸㠰⤸啊⁎獩愠琠慲獮牣灩楴湯映捡潴桴瑡爠捥杯楮敺湡楢摮潴琠敨攠桮湡散敨瑰浡牥洠瑯晩㔠ⴧ䝔孁䝃呝䅃㌭⸧䤠⁴牰浯瑯獥愠瑣癩瑩⁹景丠㕒ㅁ眠敨桰獯桰牯汹瑡摥戠⁹䥈䭐″敬摡湩潴椠据敲獡摥猠整潲摩杯湥捩朠湥硥牰獥楳湯甠潰䅣偍猠杩慮楬杮瀠瑡睨祡猠楴畭慬楴湯啊⁎獩愠戠獡捩氠略楣敮稠灩数戨䥚⥐琠慲獮牣灩楴湯映捡潴桴瑡愠瑣獡栠浯ⵯ漠敨整潲楤敭Ⱳ戠湩楤杮琠乄⁁湡敲畧慬楴杮朠湥牴湡捳楲瑰潩倨䥍㩄㤠㌷㠲㘷⸩䤠摡楤潴Ɱ攠瑸慲散汬汵牡猠杩慮獬挠湡椠摮捵潰瑳琭慲獮慬楴湯污洠摯晩捩瑡潩獮漠啊ⱎ爠獥汵楴杮椠污整敲牴湡捳楲瑰潩慮捡楴楶祴愠摮琠牡敧⁴敧敮攠灸敲獳潩倨䥍㩄㐸㐶ㄷ⤳潍敲漠敶Ⱳ椠⁴慨湵潣敶敲畭瑬灩敬氠祡牥景愠挠浯汰硥爠来汵瑡牯⁹捳敨敭椠桷捩啊⁎獩愠汢潴挠潲獳慴歬浡汰晩⁹湡湩整牧瑡楤晦牥湥⁴楳湧污潦楴獳敵搠癥汥灯敭瑮愠摮搠獩慥敳畊獩瀠敲潤業慮瑮祬渠捵敬牡扵煩極楴慮整畊潣潬慣楬敺楷桴氠獹獯浯污瀠潲整湩倨䥍㩄ㄠ㐵㤶㈹⤵桔獩愠瑮扩摯⁹獩愠爠扡楢⁴潰祬汣湯污愠瑮扩摯⁹慲獩摥愠慧湩瑳愠爠来潩景栠浵湡䨠乕潂桴瀠潨灳潨祲慬整瀨挭䨭湵 湡湵桰獯桰牯汹瑡摥映牯獭漠ⵣ畊Ɱ眠瑩楳敺景㐠ⴲ㔴欠慄愠摮㌠ⴶ㤳欠慄敲灳捥楴敶祬愠敲漠瑢楡湩猠浯硥数楲敭瑮倨䥍㩄㜱ㄲ㘰㘴⸩
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for JUN antibody 22114-1-AP | Download protocol |
| IHC protocol for JUN antibody 22114-1-AP | Download protocol |
| WB protocol for JUN antibody 22114-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
J Neuroinflammation Downregulation of CD151 restricts VCAM-1 mediated leukocyte infiltration to reduce neurobiological injuries after experimental stroke. | ||
Int Immunopharmacol IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/ PTGS2 pathway | ||
Int Immunopharmacol Anti-osteosarcoma activity of Corynoline via Src/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis | ||
Molecules Effects of the total saponins from Rosa laevigata Michx fruit against acetaminophen-induced liver damage in mice via induction of autophagy and suppression of inflammation and apoptosis. | ||
Exp Ther Med Naringin attenuates renal interstitial fibrosis by regulating the TGF-β/Smad signaling pathway and inflammation. | ||
Adv Sci (Weinh) Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer |









